2020
DOI: 10.1016/j.jphotobiol.2019.111767
|View full text |Cite
|
Sign up to set email alerts
|

Hesperidin loaded Zn2+@ SA/PCT nanocomposites inhibit the proliferation and induces the apoptosis in colon cancer cells (HCT116) through the enhancement of pro-apoptotic protein expressions

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…Next, we intersected the ferroptosis gene set obtained from FerrDb with the 19 genes and finally obtained the SLC2A1 gene (Figures 2(b) - 2(c) ). In previous studies, researchers used all-trans retinoic acid (ATRA) to treat different lung cancer cells and found that the most significant reduction in the transcription level of SLC2A1 was found in SLC2A1 and the genes in the same family, thus excluding other gene families [ 5 ]. Therefore, we determined that the SLC2A1 gene not only plays an important role in ferroptosis but also plays an indispensable role in autophagy in colon cancer.…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…Next, we intersected the ferroptosis gene set obtained from FerrDb with the 19 genes and finally obtained the SLC2A1 gene (Figures 2(b) - 2(c) ). In previous studies, researchers used all-trans retinoic acid (ATRA) to treat different lung cancer cells and found that the most significant reduction in the transcription level of SLC2A1 was found in SLC2A1 and the genes in the same family, thus excluding other gene families [ 5 ]. Therefore, we determined that the SLC2A1 gene not only plays an important role in ferroptosis but also plays an indispensable role in autophagy in colon cancer.…”
Section: Resultsmentioning
confidence: 99%
“…Colon cancer is the third most common malignant tumor in the world, the second most common cancer among females, and the third most common cancer among males, with 1.2 million new cases and more than 600,000 deaths. Survival rates have improved over the past three decades due to early detection, but the 5-year survival rate for patients diagnosed at a later stage of the disease is still only 14% [2][3][4][5]. Colon cancer remains a relatively di cult disease to treat, although advanced treatments are available which can improve survival rates for the disease.…”
Section: Introductionmentioning
confidence: 99%
“…Zn 2+ is essential for innate and adaptive immune activation and proper function of innate and adaptive immune cells, including the cytotoxic activity of NK cells and T cells [ 133 ]. Taking advantage of the excellent bioavailability of encapsulated ionotropic drugs, hesperidin-loaded Zn 2+ @ sodium alginate/pectin (SA/PCT) nanocomposites were designed to inhibit the proliferation of colon carcinoma cells and induce apoptosis under in vitro conditions [ 134 ].…”
Section: Several Breakthroughs Of Nanometallic Materials In Cancer Im...mentioning
confidence: 99%
“…Tangeretin and 5-FU synergistically up-regulate P21 in HCT-116 cells, which in turn activates the P53-mediated DNA damage response and triggers apoptosis via the JNK pathway, suggesting that the combination of tangeretin and 5-FU suppresses the autophagy pathway, enabling cancer cells susceptible to oxidative stress-induced programmed cell death [ 146 ]. Inhibition of colon cancer by hesperidin involves multiple alterations, including caspase-3-mediated apoptosis, the autophagy program initiated by PI3K/Akt/GSK-3c and mTOR pathway and, down-regulation of NF-κB and its target molecules iNOS and COX-2 to attenuate oxidative stress and enhance antioxidants to fight tumor-induced inflammation [ 147 , 148 , 149 , 150 ]. The above phenomenon also occurred in naringin-treated CRC cells, where the suppression of the PI3K/AKT/mTOR pathway resulted in ameliorated abnormal proliferation and apoptosis [ 151 ].…”
Section: Inhibitory Effect Of Crp and Its Active Components On Cancermentioning
confidence: 99%